MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0072907
Spike Pharmaceuticals Private Limited
Spike Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹84.75 Lakh
▼ 2% YoY
Net profit · FY 2024
₹21.41 Lakh
Net margin 25.3%
EBITDA · FY 2024
₹29.75 Lakh
EBITDA margin 35.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹73.15 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Spike Pharmaceuticals Private Limited
Data last updated:
Spike Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2008PTC068584. Its GSTIN is 33AAMCS2616R2ZT (Tamil Nadu).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹73.15 Lakh. It is led by directors including Vedavalli (Managing Director) and Ramaswamy Palanivelu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹84.75 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹21.41 Lakh (net margin 25.3%) and EBITDA of ₹29.75 Lakh (EBITDA margin 35.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
Spike Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0072907). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232TN2008PTC068584
Registration Number 068584
Incorporation Date 15 July 2008
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0072907
Recognitions & Rankings of Spike Pharmaceuticals
Contact details
Spike Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo.5 Nethaji Street (Second Floor), Pallikaranai, Chennai, Tamil Nadu, India – 600100
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Spike Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Spike Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Spike Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Spike Pharmaceuticals Private Limited, buy the company report.
Financials of Spike Pharmaceuticals Private Limited
FY 2025 filings availableSpike Pharmaceuticals Private Limited reported revenue of ₹84.75 Lakh (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹84.75 Lakh ▼ 2%
Net profit · FY 2024
₹21.41 Lakh margin 25.3%
EBITDA · FY 2024
₹29.75 Lakh margin 35.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 2%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 10%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 2% fall in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 35.1% | ||||
| Net Profit Margin | 25.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spike Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spike Pharmaceuticals Private Limited
Spike Pharmaceuticals has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramaswamy Palanivelu Also directs: Pattukkotai CT Scans Private Limited | Director | 10 Nov 2008 | 17 Years 11 Months | Current |
| Selvaraju Nevithitha | Director | 12 Feb 2016 | 10 Years 8 Months | Current |
| Vedavalli | Managing Director | 15 Jul 2008 | 18 Years 3 Months | Current |
| Kanakesathevar Balakrishnan Also directs: Viewsure Developers LLP, Vedhaa Balaa Farm LLP, Vista Builders and Holdings LLP and 3 more | Director | 15 Jul 2008 | 18 Years 3 Months | Current |
| Gangadurai Meenakshi | Director | 12 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Spike Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prava Pharmaceuticals Private Limited | ₹84.9 Lakh (FY 2025) | 305.0% | Hyderabad, Telangana, India | |||
| Spike Pharmaceuticals Private Limitedthis company | ₹84.75 Lakh (FY 2024) | ₹21.41 Lakh | 25.3% | -2.0% | Chennai, Tamil Nadu, India | |
| Likameda Global Private Limited | ₹84.63 Lakh (FY 2024) | 260.0% | Ahmedabad, Gujarat, India | |||
| Amokha Drugs Private Limited | ₹84.53 Lakh (FY 2025) | 2.0% | Kochi, Kerala, India |
To see the full peer comparison of Spike Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Spike Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Spike Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spike Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spike Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spike Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAMCS2616R2ZT | Tamil Nadu | Active | 29 Aug 2017 |
To see the full GST registrations and return filing status of Spike Pharmaceuticals Private Limited, buy the company report.
Recent activity
Spike Pharmaceuticals Private Limited has 9 board changes on record since 2008: 5 appointments and 4 cessations. The latest: Gangadurai Meenakshi ceased to be Additional Director on 30 Nov 2021.
AGM
Spike Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Spike Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Gangadurai Meenakshi ceased to be Additional Director.
Ceased
Selvaraju Nevithitha ceased to be Additional Director.
Appointed
Gangadurai Meenakshi was appointed as Director.
Appointed
Selvaraju Nevithitha was appointed as Director.
Ceased
Vedavalli ceased to be Director.
Ceased
Kanakesathevar Balakrishnan ceased to be Director.
Appointed
Ramaswamy Palanivelu was appointed as Director.
Appointed
Kanakesathevar Balakrishnan was appointed as Director.
Appointed
Vedavalli was appointed as Managing Director.
Incorporation
15 Jul 2008
Spike Pharmaceuticals Private Limited was registered on 15 Jul 2008 with Roc Chennai & aged 18 years 3 months as per MCA records.
Frequently asked questions
Spike Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 July 2008 (18+ years old) and is registered under CIN U24232TN2008PTC068584.
Spike Pharmaceuticals has 5 current directors:
- Vedavalli - Managing Director
- Ramaswamy Palanivelu - Director
- Selvaraju Nevithitha - Director
- Kanakesathevar Balakrishnan - Director
- Gangadurai Meenakshi - Director
The latest financial statements of Spike Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spike Pharmaceuticals is 33AAMCS2616R2ZT, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Spike Pharmaceuticals is U24232TN2008PTC068584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spike Pharmaceuticals was incorporated on 15 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Spike Pharmaceuticals by revenue are Prava Pharmaceuticals Private Limited, Likameda Global Private Limited, Amokha Drugs Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Gangadurai Meenakshi ceased to be Additional Director on 30 Nov 2021. Selvaraju Nevithitha ceased to be Additional Director on 30 Nov 2021. Gangadurai Meenakshi was appointed as Director on 12 Feb 2016. Spike Pharmaceuticals has 9 board changes on record in total.
Yes, Spike Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0072907).
The registered office of Spike Pharmaceuticals is at No.5 Nethaji Street Second Floor, Pallikaranai, Chennai, Tamil Nadu, India – 600100.
Spike Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.